Results 131 to 140 of about 81,441 (250)

Variability in ACT Response to Standard UFH Bolus During PCI: A Prospective Study on Determinants of Subtherapeutic Anticoagulation

Catheterization and Cardiovascular Interventions, Volume 107, Issue 7, Page 2293-2303, June 1, 2026.
ABSTRACT Background Unfractionated heparin (UFH) remains the standard anticoagulant during percutaneous coronary intervention (PCI), with guidelines recommending a target activated clotting time (ACT) of ≥250 s. However, despite receiving a standardized bolus dose, many patients fail to achieve this target.
Manh Cuong Vu, Antonin Trimaille, Amandine Granier, Adrien Carmona, Anis Elidrissi, Marion Kibler, Laurence Jesel, Patrick Ohlmann, Laurent Sattler, Olivier Morel   +9 more
wiley   +1 more source

Prognostic value of CTI for major adverse cardiovascular events in patients With ST-elevation myocardial infarction after primary percutaneous coronary intervention. [PDF]

Front Cardiovasc Med
Zhao Q, Fu S, Hu X, Hu X.
europepmc   +1 more source

Atrial Flutter as a Late Presentation of Scimitar Vein in an Adult With Prior ASD Repair

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Adult patients with unexplained atrial arrhythmias and right heart dilation should prompt consideration of congenital anomalies such as scimitar vein, even decades after atrial septal defect repair. Early recognition using multi‐modality imaging may prevent delayed diagnosis and progressive cardiopulmonary complications.
Fereshte Rastegarnasab, Zahra Teimouri‐Jervekani, Keyvan Khojaste, Azam Soleimani   +3 more
wiley   +1 more source

Outcomes according to timely or delayed primary percutaneous coronary intervention or fibrinolysis in a national registry of patients with ST-segment elevation myocardial infarction. [PDF]

Open Heart
Laffan J, Gao H, Street A, Coughlan JJ, Armstrong R, Maree A, Blake G, Kearney P, Crowley J, Kiernan TJ, McCreery C, Aleong G, Peace A, Kennedy M, Byrne RA.   +14 more
europepmc   +1 more source

Syncope as the Initial Presentation of Takayasu Arteritis in a 57‐Year‐Old Female: A Case Report and Literature Review

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Takayasu arteritis (TA) is a rare chronic granulomatous large‐vessel vasculitis predominantly affecting the aorta and its major branches, leading to stenosis, occlusion, or aneurysm formation. It typically presents in young women, though atypical cases can occur in older adults.
Chao Liu, Jiale Gan, Lili Feng, Yang Yang, Lianwei Dong, Jiabao Liu, Dingguo Zhang   +6 more
wiley   +1 more source

CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2026. [PDF]

Cardiovasc Interv Ther
Ozaki Y, Tobe A, Onuma Y, Miyashita K, Kobayashi Y, Amano T, Yamaji K, Ishii H, Muramatsu T, Ismail TF, Kohsaka S, Nakagawa Y, Morino Y, Uemura S, Tsujita K, Shinke T, Ako J, Yajima J, Maekawa Y, Shite J, Igarashi Y, Shiode N, Okamura A, Ogawa T, Yamaguchi J, Tamura T, Tsuji T, Hayashida K, Sugano T, Okura H, Okayama H, Kawaguchi K, Zen K, Takahashi S, Nakazato K, Suematsu N, Hironaga K, Matoba T, Iida O, Ishihara M, Ohta M, Harada M, Ozaki R, Izawa H, Murohara T, Ueno T, Nakamura M, Ikari Y, Serruys PW, Kozuma K, Task Force on Primary Percutaneous Coronary Intervention (PCI) of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT).   +50 more
europepmc   +1 more source

IVUS‐Guided Versus Angiography‐Guided PCI for Unprotected Left Main Coronary Artery Disease: A Systematic Review, Meta‐Analysis, and GRADE Assessment of Randomized Trials

Clinical Cardiology, Volume 49, Issue 6, June 2026.
graphical abstract for IVUS‐guided versus angiography‐guided pci for unprotected left main coronary artery disease. ABSTRACT Background Intravascular ultrasound (IVUS) has been increasingly used as an adjunctive tool for complex percutaneous interventions (PCIs); however, comparative randomized evidence with conventional angiography in unprotected left
Abdelrahman Elhakim, Mostafa Salem, Mohammed A. Elbahloul, Abdelrahman M. Elettreby, Mohamed A. Alsaied, Hamza A. Abdul‐Hafez, Ghaith Hussein Ahmad Al Bataineh, Maab M. Saleh, Amer Al Manla, Osama Bisht   +9 more
wiley   +1 more source

Myocardial Blush Grades Achieved After Primary Percutaneous Coronary Intervention and Their Relation to Patient Outcomes. [PDF]

Cureus
Saleem MW, Ullah I, Amjad M, Ullah S, Ullah A, Jan RU.   +5 more
europepmc   +1 more source

Moderate Intensity Statins Plus Ezetimibe Combination Therapy Versus High Intensity Statins Monotherapy After Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis

Clinical Cardiology, Volume 49, Issue 6, June 2026.
ABSTRACT Background High‐intensity statins are standard therapy after percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS), yet tolerability concerns and residual cardiovascular risk remain important challenges. Moderate‐intensity statin therapy combined with ezetimibe has emerged as a potential alternative, although its ...
Emad Uddin Sajid, Muhammad Hasnain Azeem, Alishba Fatima, Syeda Masooma Jafri, Danish Hassan, Taha Ibrahim, Kashish Zehra Manjee, Syed Rayyan Ahmed, Tooba Ali, Rida Shakeel, Muhammad Usman, Raghabendra Kumar Mahato, Danish Bawa   +12 more
wiley   +1 more source

A contemporary overview of emergency myocardial infarction hospitalizations with primary percutaneous coronary intervention in Brazil: regional trends of costs and outcomes. [PDF]

Arch Public Health
Arzumanov SA, Stephanus AD, Barreto J, Carvalho LSF, Sposito AC, Campos-Staffico AM.   +5 more
europepmc   +1 more source